| Title |
|
|
|
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
European journal of cancer | |
| Publication |
|
|
|
2018
| |
| ISSN |
|
|
|
0959-8049
1879-0852
| |
| Volume/pages |
|
|
|
103(2018), p. 184-194
| |
| ISI |
|
|
|
000447292100023
| |
| Pubmed ID |
|
|
|
30267987
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|